Long-term association of inhaled corticosteroids and long-acting β2-agonists with lung function decline in asthma: results from the ECRHS II

R. de Marco, A. Marcon, C. Janson, M. Bugiani, I. Cerveri, A. Corsico, D. Gislason, A. Gulsvik, I. Pin, D. Jarvis (Verona, Italy)

Source: Annual Congress 2005 - Burden and management of obstructive airway diseases
Session: Burden and management of obstructive airway diseases
Session type: Poster Discussion
Number: 1421
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. de Marco, A. Marcon, C. Janson, M. Bugiani, I. Cerveri, A. Corsico, D. Gislason, A. Gulsvik, I. Pin, D. Jarvis (Verona, Italy). Long-term association of inhaled corticosteroids and long-acting β2-agonists with lung function decline in asthma: results from the ECRHS II. Eur Respir J 2005; 26: Suppl. 49, 1421

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled corticosteroids and FEV1 decline in asthma: an international cohort study
Source: International Congress 2018 – Asthma in children and adults: long-term aspects
Year: 2018



Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004

Role of tiotropium in reducing exacerbations in COPD patients when added to long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS): The OUTPUL study
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD
Source: Eur Respir J, 54 (6) 1900521; 10.1183/13993003.00521-2019
Year: 2019



Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001

Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis
Source: Eur Respir J 2004; 23: 552-558
Year: 2004



Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 341s
Year: 2004

Severe exacerbations, decline in lung function and inhaled budesonide in asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007

The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Meta-analysis of inhaled corticosteroids response in children with asthma.
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019


Effects of adding salmeterol to inhaled corticosteroids on lung function and quality of life in patients with mild persistent asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 499s
Year: 2006

The effects of early intervention with inhaled budesonide on lung function in mild persistent asthma: results from the START study
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003

Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial
Source: Eur Respir J 2007; 30: 457-466
Year: 2007



Children with mild asthma: do they benefit from inhaled corticosteroids?
Source: Eur Respir J 2002; 20: 1470-1475
Year: 2002



The effect of smoking on severity of asthma and quality of life in patients treated with inhaled corticosteroids and long-acting b2-agonist (ICS/LABA)
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Effect of inhaled beta2 agonist on lung compliance in patients with COPD with poor bronchodilator response
Source: Eur Respir J 2006; 28: Suppl. 50, 428s
Year: 2006

Obesity and the response to inhaled budesonide in patients with asthma
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007


Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: Design and planned analyses
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness
Source: Eur Respir J 2006; 27: 1144-1151
Year: 2006



Acute bronchodilator responsiveness in a global respiratory trial (UPLIFT) following maximal inhaled bronchodilators
Source: Eur Respir J 2005; 26: Suppl. 49, 716s
Year: 2005